Changes in the cerebrospinal fluid proteome precede and stratify the course of Parkinson’s Disease

Author:

Tsukita KazutoORCID,Sakamaki-Tsukita Haruhi,Kaiser Sergio,Zhang Luqing,Messa Mirko,Serrano-Fernandez Pablo,Takahashi Ryosuke

Abstract

AbstractThe proteome encodes for various information. By quantifying 4071 human proteins in the cerebrospinal fluid using high-throughput affinity proteomics, this study aimed to extract proteomic signatures associated with Parkinson’s disease using unbiased machine-learning and to examine their impact on Parkinson’s disease course.From the Parkinson’s Progression Markers Initiative, we first included 312 drug-naïve patients with Parkinson’s disease without GBA1, LRRK2, and SNCA mutations (non-genetic Parkinson’s disease) and 161 healthy controls. Differentially expressed protein analysis identified 149 proteins that were likely to be differentially expressed with a false discovery rate of ≤ 0.2. Subsequently, a logistic regression analysis with the least absolute shrinkage and selection operator created a 55-protein-based model that quantified the degree to which non-genetic Parkinson’s disease-associated cerebrospinal fluid proteomic signatures were present in each participant in the form of a score named a “non-genetic Parkinson’s disease-associated proteomic score.” This score accurately distinguished non-genetic Parkinson’s disease from healthy controls in both a derivation cohort (area under the curve = 0.91 [95% confidence interval, 0.89–0.94]) and an independent validation cohort comprising 38 drug-naïve patients with non-genetic Parkinson’s disease and 15 healthy controls (area under the curve = 0.87 [95% confidence interval, 0.76–0.99]).Notably, this score was also significantly increased in patients with Parkinson’s disease harboring GBA1, LRRK2, or SNCA mutations (n = 258), albeit to varying degrees depending on the type of mutation. Furthermore, the score of genetic prodromal individuals (n = 365) was intermediate between that of healthy controls and patients with Parkinson’s disease.Next, cross-sectional correlation analyses revealed that regardless of the presence or absence of genetic mutations, this score was significantly correlated with several baseline clinical parameters and biomarkers. Furthermore, longitudinal survival analyses revealed that even after adjustment of baseline characteristics, this score significantly predicted progression to important clinical milestones including mild cognitive impairment, dementia, and Hoehn and Yahr stage IV. Finally, longitudinal analyses using linear-mixed effects models confirmed that even after adjustment of baseline characteristics, the score was significantly associated with subsequent motor and cognitive decline.Collectively, our study demonstrated that cerebrospinal fluid proteomic signatures associated with non-genetic Parkinson’s disease could be quantified using a novel non-genetic Parkinson’s disease-associated proteomic score. Furthermore, we identified the presence of these signatures in genetic Parkinson’s disease to varying degrees depending on the type of mutation. Moreover, these signatures appeared from the prodromal stage and were robustly linked to both subsequent motor and cognitive decline in early Parkinson’s disease, indicating that the cerebrospinal fluid proteome encodes important information for both the onset and progression of Parkinson’s disease.

Publisher

Cold Spring Harbor Laboratory

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3